Global Dynamics: Clinical Oncology NG Market Region Analysis
A granular Clinical Oncology NG Market region analysis shows that North America currently maintains a dominant position, capturing approximately 48% of the global revenue. This leadership is fueled by a highly developed biotech ecosystem, high healthcare spending, and favorable reimbursement codes (such as those from CMS) for NGS-based tumor profiling. The presence of industry pioneers like...
0 Comentários 0 Compartilhamentos 32 Visualizações 0 Anterior